Ajanta Pharma has released the written transcript of its Q1 FY27 earnings call, which took place on July 30, 2026. The transcript details discussions on the company’s financial performance and outlook. Investors can access this important document, which has been uploaded to the company’s website, providing further insights into the company’s strategy and recent results.
Ajanta Pharma Releases Q1 FY27 Earnings Call Transcript
Ajanta Pharma Limited has officially published the written transcript from its earnings call held on July 30, 2026. This disclosure is made in compliance with SEBI regulations and provides shareholders and interested parties with a detailed account of the discussions held during the call. The earnings call, which commenced at 4:15 p.m., covered the company’s performance for the first quarter of the financial year 2027 (Q1 FY27).
Accessing the Transcript
The complete transcript is now available on the company’s official website. Investors and stakeholders can access the document, which offers insights into the company’s financial results, operational highlights, and future strategies discussed during the call. The link to the transcript is provided for easy access: https://www.ajantapharma.com/assets/frontend/images/investors/files/quarterly%20results/1785751785%20Earnings-Call-Transcript-Q1-(Apr-Jun)-2026-27.pdf. This information is intended for investor reference and record-keeping.
Source: BSE
